Mortality in Patients with Biopsy-proven Giant Cell Arteritis: A South Australian Population-based Study

REFERENCES

1. 1.↵
   1. Gouet D,
   2. Marechaud R,
   3. Alcalay M

   . Survival in giant cell arteritis: a 14-year survey of 87 patients. J Rheumatol 1985;12:1209–10.

   OpenUrlPubMed
2. 2.↵
   1. Gonzalez-Gay MA,
   2. Blanco R,
   3. Abraira V,
   4. García-Porrúa C,
   5. Ibáñez D,
   6. García-Pais MJ,
   7. et al.

   Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171–6.

   OpenUrlPubMed
3. 3.↵
   1. Gran JT,
   2. Myklebust G,
   3. Wilsgaard T,
   4. Jacobsen BK

   . Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 2001;40:1238–42.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Garcia-Porrua C,
   2. Blanco FJ,
   3. Atanes A,
   4. Freire M,
   5. Graña J,
   6. Galdo F

   . Giant cell arteritis (GCA): survival analysis of 54 patients from Galicia, Spain [abstract]. Arthritis Rheum 1996;39 Suppl:S64.

   OpenUrlCrossRef
5. 5.↵
   1. Graham E,
   2. Holland A,
   3. Avery A,
   4. Russell RW

   . Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981;282:269–71.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Hill CL,
   2. Cole A,
   3. Rischmueller M,
   4. Dodd T,
   5. Coleman M,
   6. Tucker G,
   7. et al.

   Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology 2010;49:756–9.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Nordborg E,
   2. Bengtsson BA

   . Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549–50.

   OpenUrlFREE Full Text
8. 8.↵
   1. Crow RW,
   2. Katz BJ,
   3. Warner JE,
   4. Alder SC,
   5. Zhang K,
   6. Schulman S,
   7. et al.

   Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci 2009;64:365–9.

   OpenUrlPubMed
9. 9.↵
   1. Bisgard C,
   2. Sloth H,
   3. Keiding N,
   4. Juel K

   . Excess mortality in giant cell arteritis. J Intern Med 1991;230:119–23.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Nesher G,
    2. Sonnenblick M,
    3. Friedlander Y

    . Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol 1994;21:1283–6.

    OpenUrlPubMed
11. 11.↵
    1. Uddhammar A,
    2. Eriksson AL,
    3. Nyström L,
    4. Stenling R,
    5. Rantapää-Dahlqvist S

    . Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737–42.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Matteson EL,
    2. Gold KN,
    3. Bloch DA,
    4. Hunder GG

    . Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193–6.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Salvarani C,
    2. Cantini F,
    3. Boiardi L,
    4. Hunder GG

    . Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261–71.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Huston KA,
    2. Hunder GG,
    3. Lie JT,
    4. Kennedy RH,
    5. Elveback LR

    . Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162–7.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Scola CJ,
    2. Li C,
    3. Upchurch KS

    . Mesenteric involvement in giant cell arteritis. An underrecognised complication? Analysis of a case series with clinicoanatomic correlation. Medicine 2008;87:45–51.

    OpenUrlCrossRefPubMed